262 related articles for article (PubMed ID: 31766724)
1. A "NOTCH" Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer.
Kar R; Jha NK; Jha SK; Sharma A; Dholpuria S; Asthana N; Chaurasiya K; Singh VK; Burgee S; Nand P
Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31766724
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT.
De Francesco EM; Maggiolini M; Musti AM
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29996493
[TBL] [Abstract][Full Text] [Related]
3. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition in breast cancer progression and metastasis.
Wang Y; Zhou BP
Chin J Cancer; 2011 Sep; 30(9):603-11. PubMed ID: 21880181
[TBL] [Abstract][Full Text] [Related]
5. Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer.
Kim RK; Kaushik N; Suh Y; Yoo KC; Cui YH; Kim MJ; Lee HJ; Kim IG; Lee SJ
Oncotarget; 2016 Aug; 7(33):53430-53442. PubMed ID: 27462787
[TBL] [Abstract][Full Text] [Related]
6. Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells.
Chen X; Xiao W; Liu X; Zeng M; Luo L; Wu M; Ye S; Liu Y
Curr Mol Med; 2014 May; 14(4):523-34. PubMed ID: 24694299
[TBL] [Abstract][Full Text] [Related]
7. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.
Zhang J; Shao X; Sun H; Liu K; Ding Z; Chen J; Fang L; Su W; Hong Y; Li H; Li H
Oncotarget; 2016 Sep; 7(38):61036-61053. PubMed ID: 27506933
[TBL] [Abstract][Full Text] [Related]
8. BMP-4 enhances epithelial mesenchymal transition and cancer stem cell properties of breast cancer cells via Notch signaling.
Choi S; Yu J; Park A; Dubon MJ; Do J; Kim Y; Nam D; Noh J; Park KS
Sci Rep; 2019 Aug; 9(1):11724. PubMed ID: 31409851
[TBL] [Abstract][Full Text] [Related]
9. cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.
Chen L; Fu H; Luo Y; Chen L; Cheng R; Zhang N; Guo H
Cell Death Dis; 2017 Apr; 8(4):e2728. PubMed ID: 28383549
[TBL] [Abstract][Full Text] [Related]
10. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
11. Regulation of EMT by Notch signaling pathway in tumor progression.
Li Y; Ma J; Qian X; Wu Q; Xia J; Miele L; Sarkar FH; Wang Z
Curr Cancer Drug Targets; 2013 Nov; 13(9):957-62. PubMed ID: 24168187
[TBL] [Abstract][Full Text] [Related]
12. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network.
Yang J; Hou Y; Zhou M; Wen S; Zhou J; Xu L; Tang X; Du YE; Hu P; Liu M
Int J Biochem Cell Biol; 2016 Feb; 71():62-71. PubMed ID: 26693891
[TBL] [Abstract][Full Text] [Related]
13. 3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway.
Chen J; Chang H; Peng X; Gu Y; Yi L; Zhang Q; Zhu J; Mi M
Sci Rep; 2016 Jun; 6():28858. PubMed ID: 27345219
[TBL] [Abstract][Full Text] [Related]
14. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
15. Notch signaling and breast cancer.
Reedijk M
Adv Exp Med Biol; 2012; 727():241-57. PubMed ID: 22399352
[TBL] [Abstract][Full Text] [Related]
16. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
17. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.
Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK
Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070
[TBL] [Abstract][Full Text] [Related]
18. DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation.
Faronato M; Nguyen VT; Patten DK; Lombardo Y; Steel JH; Patel N; Woodley L; Shousha S; Pruneri G; Coombes RC; Magnani L
Oncotarget; 2015 Sep; 6(26):22467-79. PubMed ID: 26093085
[TBL] [Abstract][Full Text] [Related]
19. Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer.
Bui QT; Im JH; Jeong SB; Kim YM; Lim SC; Kim B; Kang KW
Cancer Lett; 2017 Apr; 390():115-125. PubMed ID: 28108315
[TBL] [Abstract][Full Text] [Related]
20. MAML1 regulates EMT markers expression through NOTCH-independent pathway in breast cancer cell line MCF7.
Shariat Razavi SM; Forghanifard MM; Kordi-Tamandani DM; Abbaszadegan MR
Biochem Biophys Res Commun; 2019 Mar; 510(3):376-382. PubMed ID: 30732857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]